PODCAST: First rounders: Christoph Lengauer
Sign Up to like & getrecommendations! Published in 2018 at "Nature Biotechnology"
DOI: 10.1038/nbt1118-1030b
Abstract: In an unusual move, Gilead Sciences said in September that it will sell generic versions of its own hepatitis C virus (HCV) drugs in the US through a subsidiary, Asegua Therapeutics. These ‘authorized generics’ will… read more here.
Keywords: first rounders; rounders christoph; gilead; market ... See more keywords